Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for female hair loss has low side effects, more research needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.